Long lasting major response to pembrolizumab in a thoracic malignant rhabdoid-like SMARCA4-deficient tumor. (22nd May 2019) - Henon, C; Blay, J -Y; Massard, C; Mir, O; Bahleda, R; Dumont, S; Postel-Vinay, S; Adam, J; Soria, J -C; Le Cesne, A